Diagnostic and Therapeutic Endoscopy

Diagnostic and Therapeutic Endoscopy / 1999 / Article

Open Access

Volume 6 |Article ID 434579 | https://doi.org/10.1155/DTE.6.9

Harubumi Kato, Tetsuya Okunaka, Takaaki Tsuchida, Hiroshi Shibuya, Shiro Fujino, Kyoko Ogawa, "Analysis of the Cost-effectiveness of Photodynamic Therapy in Early Stage Lung Cancer", Diagnostic and Therapeutic Endoscopy, vol. 6, Article ID 434579, 8 pages, 1999. https://doi.org/10.1155/DTE.6.9

Analysis of the Cost-effectiveness of Photodynamic Therapy in Early Stage Lung Cancer

Accepted13 May 1999


Methods A cost-effectiveness analysis was carried out for photodynamic therapy (PDT) performed in early stage lung cancer cases, which by definition have no lymph node metastasis. The alternative treatment method was lobectomy, which conventionally would have been the first choice of treatment. Costs (C) and effectiveness (E) both of the PDT group and operation group were compared. Effectiveness was determined using quality adjusted life years saved (QALYs) which is the 5-year survival rate adjusted in terms of the quality of life of the patient, and the cost-effectiveness rate was obtained based on the costs of treatment methods during the patient's stay in the hospital. Health care costs, including drugs, were calculated according to the 1992 National Health Insurance list in yen. Costs which were non-reimbursable by the public insurance system, such as for special rooms and sun block cream, were also expressed in yen.Results The total cost of the operated group was ¥1,793,832 and that for the PDT group was ¥1,017,104. The cost-effectiveness rate of the operated group, that is the average cost of treatment per postoperative living month, was ¥37,537, while that of the entire PDT group was ¥30,003. This indicates that the cost-effectiveness rate for the operated group is apparently 1.3 times higher than that of the PDT group. The monthly cost-effectiveness rate for the PDT group of lesions smaller than 2 cm was ¥25,533. Therefore the cost in the operated group is 1.5 times higher.Conclusions This study demonstrated the merits of PDT for early stage lung cancer from the point of view of cost-effectiveness.

Copyright © 1999 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.